Embecta is a company based in the United States, operating within the manufacturing sector, specifically focusing on medical devices and equipment. Established in 1924, Embecta has positioned itself as a key player in the healthcare industry, particularly in the realm of diabetes management and safety solutions for healthcare professionals. The company emphasizes the importance of reducing needlestick injuries (NSIs) among healthcare workers, as evidenced by a recent case study that explored a strategic collaboration aimed at improving safety practices within health systems. This project highlighted a multifaceted approach that included product standardization, safe practice education, and the implementation of the BD SafetyGlide™ insulin syringe, designed to minimize the risk of NSIs. The study reported significant reductions in the incidence of NSIs and associated costs, demonstrating Embecta's commitment to enhancing healthcare worker safety through innovative solutions and quality improvement initiatives. With a workforce ranging from 1,001 to 5,000 employees and substantial annual revenue, Embecta continues to contribute to advancements in medical device manufacturing and healthcare services.